Halbert Hargrove Global Advisors’s Biogen BIIB Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2	Closed	-$491	–	391
2026 Q2	$491	Buy	+2	New	+$383	﹤0.01%	535
2015 Q3	–	Sell	-1,438	Closed	-$581K	–	106
2015 Q2	$581K	Sell	1,438 -58	-4%	-$23.3K	0.14%	64
2015 Q1	$632K	Buy	1,496 +626	+72%	+$247K	0.2%	60
2014 Q4	$295K	Buy	870 +32	+4%	+$10.4K	0.15%	87
2014 Q3	$277K	Sell	838 -591	-41%	-$195K	0.08%	103
2014 Q2	$451K	Sell	1,429 -184	-11%	-$55.4K	0.14%	52
2014 Q1	$493K	Sell	1,613 -163	-9%	-$51.7K	0.15%	42
2013 Q4	$497K	Buy	1,776 +478	+37%	+$124K	0.15%	43
2013 Q3	$313K	Sell	1,298 -84	-6%	-$18.8K	0.1%	76
2013 Q2	$297K	Buy	+1,382	New	+$295K	0.11%	79

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Nippon Life Global Investors Americas New York $2.51B AUM 38.65% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Halbert Hargrove Global Advisors's BIIB Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of Biogen (BIIB) in Q3 2026, closing a stake of 2 shares — an estimated $491 sold.

Halbert Hargrove Global Advisors first reported a position in BIIB in Q2 2013 and held it in 10 quarters. The position peaked at $632K in Q1 2015. 362 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Halbert Hargrove Global Advisors reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
Halbert Hargrove Global Advisors sold 2 Biogen shares in Q3 2026, an estimated $491.
Halbert Hargrove Global Advisors first reported a position in Biogen in Q2 2013 and held it in 10 quarters.
Halbert Hargrove Global Advisors's Biogen position peaked at $632K in Q1 2015.
362 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.